From preclinical evidence to public expectation: ethical and clinical implications of miscommunicated cancer research
Abstract
The communication of preclinical cancer research to the public represents a critical interface between science and clinical practice...
References
- Retraction for Liaki et al., A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance. Proc Natl Acad Sci U S A 2026;123:e2612385123. DOI: https://doi.org/10.1073/pnas.2612385123
- Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025. CA Cancer J Clin 2025;75:10-45. DOI: https://doi.org/10.3322/caac.21871
- Begley CG, Ellis LM. Drug development: raise standards for preclinical cancer research. Nature 2012;483:531-3. DOI: https://doi.org/10.1038/483531a
- Boutron I, Ravaud P. Misrepresentation and distortion of research in biomedical literature. Proc Natl Acad Sci U S A 2018;115:2613-9. DOI: https://doi.org/10.1073/pnas.1710755115
- Ouanes K. Generative artificial intelligence in healthcare: current status and future directions. Ital J Med 2024;18:1782. DOI: https://doi.org/10.4081/itjm.2024.1782
- Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2:e124. DOI: https://doi.org/10.1371/journal.pmed.0020124
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2026 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.